全文获取类型
收费全文 | 578篇 |
免费 | 18篇 |
专业分类
儿科学 | 36篇 |
妇产科学 | 28篇 |
基础医学 | 63篇 |
口腔科学 | 17篇 |
临床医学 | 41篇 |
内科学 | 103篇 |
皮肤病学 | 3篇 |
神经病学 | 54篇 |
特种医学 | 56篇 |
外科学 | 77篇 |
综合类 | 4篇 |
一般理论 | 2篇 |
预防医学 | 33篇 |
眼科学 | 3篇 |
药学 | 30篇 |
肿瘤学 | 46篇 |
出版年
2022年 | 11篇 |
2021年 | 19篇 |
2020年 | 7篇 |
2019年 | 21篇 |
2018年 | 10篇 |
2017年 | 6篇 |
2016年 | 8篇 |
2015年 | 14篇 |
2014年 | 19篇 |
2013年 | 32篇 |
2012年 | 29篇 |
2011年 | 40篇 |
2010年 | 13篇 |
2009年 | 20篇 |
2008年 | 43篇 |
2007年 | 32篇 |
2006年 | 21篇 |
2005年 | 19篇 |
2004年 | 23篇 |
2003年 | 16篇 |
2002年 | 21篇 |
2001年 | 19篇 |
2000年 | 13篇 |
1999年 | 9篇 |
1998年 | 6篇 |
1997年 | 3篇 |
1996年 | 4篇 |
1995年 | 2篇 |
1994年 | 5篇 |
1993年 | 7篇 |
1992年 | 5篇 |
1991年 | 13篇 |
1990年 | 9篇 |
1989年 | 6篇 |
1988年 | 5篇 |
1987年 | 12篇 |
1986年 | 6篇 |
1985年 | 9篇 |
1984年 | 6篇 |
1983年 | 7篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1976年 | 3篇 |
1944年 | 1篇 |
1943年 | 2篇 |
1930年 | 2篇 |
1899年 | 1篇 |
1898年 | 1篇 |
1897年 | 1篇 |
1896年 | 1篇 |
排序方式: 共有596条查询结果,搜索用时 78 毫秒
81.
Antonio Tabilio William Vainchenker Daniel Van Haecke Giovanna Vinci Josette Guichard Annie Henri Félix Reyes Janine Breton-Gorius 《Leukemia research》1984,8(5):769-781
Twenty cases of leukemia involving platelet precursors have been identified by a panel of monoclonal and polyclonal antiplatelet antibodies and by the ultrastructural demonstration of platelet peroxidase (PPO). The two techniques were in close agreement both for identification and for the quantitation of the blast cells except in three cases where PPO was present in the absence of the immunological markers. The immunological appearance of the leukemic megakaryocytic precursors was identical to that of their normal counterparts; the cells were positive with J 15 (anti GP IIb-IIIa complex), C 17 (anti GP IIIa), J 2 (anti GP 26,000) AN 51 (anti GP Ib). A diffuse cytoplasmic labelling was observed with anti factor VIII vwF and anti platelet factor 4 (PF 4). In addition, the leukemic maturation was quite similar to normal megakaryocyte differentiation since in micromegakaryocytes the expression of Gp Ib was strong and an intense granular pattern of labelling with anti factor VIII vwF and anti PF 4 was observed. In no case was the leukemic megakaryocytic series labelled by anti-erythroid antibodies, anti myeloid antibodies or J 5, B 1, OKT 11 antibodies. Using ultrastructural immunoferritin with J 15 it was possible to demonstrate that labelling with this antibody only occured on PPO-positive cells. Immunogold or peroxidase labelling with AN 51 at the EM level in cases of mixed leukemia showed that Gp Ib was absent from proerythroblasts and myeloblasts. Therefore, in no case were specific platelet markers expressed in the leukemias of other cell lineages. 相似文献
82.
83.
Carbonic anhydrase I is an early specific marker of normal human erythroid differentiation 总被引:2,自引:0,他引:2
Villeval JL; Testa U; Vinci G; Tonthat H; Bettaieb A; Titeux M; Cramer P; Edelman L; Rochant H; Breton-Gorius J 《Blood》1985,66(5):1162-1170
The expression of carbonic anhydrase (CA) as a marker of erythroid differentiation was investigated by immunologic and enzymatic procedures. A polyclonal anti-CA antibody was obtained by immunizing rabbits with purified CA I isozyme. This antibody is reactive with CA I but not with CA II. Within blood cells, CA I was only present in erythrocytes, whereas CA II was also detected in platelet lysates by enzymatic assay. Concerning marrow cells, identifiable erythroblasts and some blast cells expressed CA I. Most of the glycophorin A-positive marrow cells were clearly labeled by the anti-CA I antibody. However, rare CA I-positive cells were not reactive with anti-glycophorin A antibodies. We therefore investigated whether these cells were erythroid precursors or progenitors. In cell sorting experiments of marrow cells with the FA6 152 monoclonal antibody, which among hematopoietic progenitors is reactive only with CFU-E and a part of BFU- E, was performed, CA I+ cells were found mainly in the positive fraction. The percentage of CA I+ cells nonreactive with anti- glycophorin A antibodies contained in the two fractions was in the same range as the percentage of erythroid progenitors identified by their capacity to form colonies. In addition, the anti-CA I antibody labeled blood BFU-E-derived colonies as early as day 6 of culture, whereas in similar experiments with the anti-glycophorin A antibodies, they were stained three or four days later. No labeling was observed in CFU-GM- or CFU-MK-derived colonies. The phenotype of the day 6 cells expressing CA I was similar to that of erythroid progenitors (CFU-E or BFU-E): negative for glycophorin A and hemoglobin, and positive for HLA-DR antigen, the antigen identified by FA6 152, and blood group A antigen. Among the cell lines tested, only HEL cells expressed CA I, while K562 was unlabeled by the anti-CA I antibody. In contrast, HEL and K562 cells expressed CA II as detected by a biochemical technique. Synthesis of CA I, as with other erythroid markers such as glycophorin A and hemoglobin, was almost abolished after 12-O-tetradecanoyl-phorbol-13 acetate treatment of HEL cells. In conclusion, CA I appears to be an early specific marker of the erythroid differentiation, expressed by a cell with a similar phenotype as an erythroid progenitor. 相似文献
84.
85.
86.
p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma 总被引:7,自引:0,他引:7
Di Vinci A Perdelli L Banelli B Salvi S Casciano I Gelvi I Allemanni G Margallo E Gatteschi B Romani M 《International journal of cancer. Journal international du cancer》2005,114(3):414-421
The potential role of p16(INK4a) methylation in breast cancer is controversial whereas there are no data on fibroadenoma. To assess if inactivation of p16(INK4a) by promoter hypermethylation occurs in this hyperproliferative benign breast lesion or, on the contrary, it is strictly related to the carcinogenic process, we have tested the different histological components of 15 cases of fibroadenoma and the intraductal and infiltrating components of 15 cases of carcinoma and their adjacent non-tumoral epithelium. All samples were obtained by laser-assisted microdissection. The relationship between promoter methylation status, immunohistochemical protein expression and ki67 proliferative activity was evaluated for each lesion. Our data demonstrate that hypermethylation of p16(INK4a) promoter is a common event occurring at similar frequency in all the different histological areas of the benign and malignant breast lesions taken into exam. Conversely, protein p16 expression, although heterogeneously distributed within the section, is considerably higher in breast carcinoma as compared to fibroadenoma in both tumoral and non-tumoral epithelia and stroma. The protein localization was almost exclusively nuclear in fibroadenoma and non-tumoral epithelia whereas, in carcinoma, the staining was both nuclear and cytoplasmic or cytoplasmic alone. Furthermore, in a subset of fibroadenoma with higher proliferative activity, p16 protein expression was substantially decreased as compared to those showing lower proliferation. We did not observe this association in carcinomas. Our data demonstrate that the hypermethylation of the p16(INK4a) promoter is not specifically associated with malignancy and that, on the contrary, the overexpression of p16 and its cytoplasmic sequestration is a feature of breast carcinoma. 相似文献
87.
Banelli B Brigati C Di Vinci A Casciano I Forlani A Borzì L Allemanni G Romani M 《Laboratory investigation; a journal of technical methods and pathology》2012,92(3):458-465
Epigenetic alterations are hallmarks of cancer and powerful biomarkers, whose clinical utilization is made difficult by the absence of standardization and of common methods of data interpretation. The coordinate methylation of many loci in cancer is defined as 'CpG island methylator phenotype' (CIMP) and identifies clinically distinct groups of patients. In neuroblastoma (NB), CIMP is defined by a methylation signature, which includes different loci, but its predictive power on outcome is entirely recapitulated by the PCDHB cluster only. We have developed a robust and cost-effective pyrosequencing-based assay that could facilitate the clinical application of CIMP in NB. This assay permits the unbiased simultaneous amplification and sequencing of 17 out of 19 genes of the PCDHB cluster for quantitative methylation analysis, taking into account all the sequence variations. As some of these variations were at CpG doublets, we bypassed the data interpretation conducted by the methylation analysis software to assign the corrected methylation value at these sites. The final result of the assay is the mean methylation level of 17 gene fragments in the protocadherin B cluster (PCDHB) cluster. We have utilized this assay to compare the methylation levels of the PCDHB cluster between high-risk and very low-risk NB patients, confirming the predictive value of CIMP. Our results demonstrate that the pyrosequencing-based assay herein described is a powerful instrument for the analysis of this gene cluster that may simplify the data comparison between different laboratories and, in perspective, could facilitate its clinical application. Furthermore, our results demonstrate that, in principle, pyrosequencing can be efficiently utilized for the methylation analysis of gene clusters with high internal homologies. 相似文献
88.
Garofalo R Conti M Massazza G Cesari E Vinci E Castagna A 《Musculoskeletal surgery》2011,95(Z1):S25-S29
Subcoracoid impingement syndrome represents a rare cause of shoulder pain. To date, there are a few papers in literature that have addressed specifically the subcoracoid impingement. We reviewed 13 consecutive patients suffering from this syndrome who underwent an arthroscopic treatment. There were 4 men and 9 women with a mean age of 45 years (range, 23-58 years). The diagnosis of subcoracoid impingement was carried out on the basis of clinical examination and magnetic resonance imaging finding. Arthroscopic surgery consisted of a coracoplasty alone in 2 patients, coracoplasty and acromioplasty in 2 patients, coracoplasty and subscapularis tendon repair in 4 patients, and in the last 5 patients no coracoplasty was done and surgery consisted in treating a minor shoulder instability. Patients were reviewed at a mean follow-up of 2.4 ± 0.7 years. We evaluated the difference between preoperative and final postoperative range of motion, VAS, UCLA, SST and Constant score using a Student's t test. At follow-up, we observed a significant improvement in range of motion and shoulder scores; moreover, clinical findings of subcoracoid impingement were negative in all patients. Different pathological shoulder conditions can be responsible for a subcoracoid impingement that can be primary or secondary to factors different from mechanic attrition against the coracoid because of its morphology. In case of primary impingement, coracoplasty is a good treatment to relieve clinical symptoms. In patients suffering from an associated minor shoulder instability with MGHL capsulolabral lesion, surgical treatment of this lesion without coracoplasty led to the improvement in symptoms. 相似文献
89.
Gynecomastia may result in psychological problems because the presence of a "feminized" chest changes the male body contour, altering the masculine ideal of virility. Currently, surgical techniques described for the correction of gynecomastia are for some patients associated with aesthetically unacceptable scars, sometimes less tolerated than the chest deformity itself. The case of a 20-year-old man who underwent the authors' male chest body-contouring technique with minimal visible scars is described. 相似文献
90.
Roberto Ivan Troisi Jacques Van Huysse Frederik Berrevoet Bert Vandenbossche Mauricio Sainz-Barriga Alessio Vinci Salvatore Ricciardi Tommaso Bocchetti Xavier Rogiers Bernard de Hemptinne 《Surgical endoscopy》2011,25(1):79-87